Global Rare Biomarkers Specimen Collection And Stabilization Market Size & Outlook
Global rare biomarkers specimen collection and stabilization market, 2018-2030 (US$M)
Related Markets
Global rare biomarkers specimen collection and stabilization market highlights
- The global rare biomarkers specimen collection and stabilization market generated a revenue of USD 41,973.9 million in 2024 and is expected to reach USD 92,386.7 million by 2030.
- The market is expected to grow at a CAGR (2025 - 2030) of 14.4% by 2030.
- In terms of segment, circulating cell free dna (ccfdna) accounted for a revenue of USD 16,805.6 million in 2024.
- Circulating Cell Free RNA (ccfRNA) / miRNA is the most lucrative biomarker segment registering the fastest growth during the forecast period.
- In terms of region, North America was the largest revenue generating market in 2024.
- Country-wise, India is expected to register the highest CAGR from 2025 to 2030.
Global data book summary
| Market revenue in 2024 | USD 41,973.9 million |
| Market revenue in 2030 | USD 92,386.7 million |
| Growth rate | 14.4% (CAGR from 2025 to 2030) |
| Largest segment | Circulating cell free dna (ccfdna) |
| Fastest growing segment | Circulating Cell Free RNA (ccfRNA) / miRNA |
| Historical data covered | 2018 - 2023 |
| Base year for estimation | 2024 |
| Forecast period covered | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Circulating Cell Free DNA (ccfDNA), Circulating Tumor Cells (CTCs), Exosomes/Extracellular Vesicles, Circulating Cell Free RNA (ccfRNA) / miRNA |
Other key industry trends
- In terms of revenue, the North America accounted for 52.1% of the global rare biomarkers specimen collection and stabilization market in 2024.
- By country, the U.S. is projected to lead the global market in terms of revenue in 2030.
- By country, India is the fastest growing regional market and is projected to reach USD 3,190.4 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Rare Biomarkers Specimen Collection And Stabilization Market Scope
Rare Biomarkers Specimen Collection And Stabilization Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Global rare biomarkers specimen collection and stabilization market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to rare biomarkers specimen collection and stabilization market will help companies and investors design strategic landscapes.
Circulating cell free dna (ccfdna) was the largest segment with a revenue share of 40.04% in 2024. Horizon Databook has segmented the Global rare biomarkers specimen collection and stabilization market based on circulating cell free dna (ccfdna), circulating tumor cells (ctcs), exosomes/extracellular vesicles, circulating cell free rna (ccfrna) / mirna covering the revenue growth of each sub-segment from 2018 to 2030.
- Global Rare Biomarkers Specimen Collection And Stabilization Biomarker Outlook (Revenue, USD million, 2018-2030)
- Circulating Cell Free DNA (ccfDNA)
- Circulating Tumor Cells (CTCs)
- Exosomes/Extracellular Vesicles
- Isolation Kits & Reagents
- Blood Collection Tubes
- Systems
- Circulating Cell Free RNA (ccfRNA) / miRNA
- Isolation Kits & Reagents
- Blood Collection Tubes
- Global Rare Biomarkers Specimen Collection And Stabilization End Use Outlook (Revenue, USD million, 2018-2030)
- Research
- Research Labs/CROs
- Academic Institutes
- Diagnostics
- Laboratories
- Hospitals
- Prenatal Clinics
- Research
Reasons to subscribe to Global rare biomarkers specimen collection and stabilization market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Global rare biomarkers specimen collection and stabilization market databook
-
Our clientele includes a mix of rare biomarkers specimen collection and stabilization market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of global-level data and insights on the Global rare biomarkers specimen collection and stabilization market , including forecasts for subscribers. This global databook contains high-level insights into Global rare biomarkers specimen collection and stabilization market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Global rare biomarkers specimen collection and stabilization market size, by regions, 2018-2030 (US$M)
Top 10 countries: Rare biomarkers specimen collection and stabilization market size, 2024 (US$M)
Global rare biomarkers specimen collection and stabilization market share, by biomarker, 2024 & 2030 (%, US$M)
Rare biomarkers specimen collection and stabilization market: Opportunity assessment by country
Global rare biomarkers specimen collection and stabilization market, by region, 2024 (US$M)
Global rare biomarkers specimen collection and stabilization market size, by regions, 2018-2030 (US$M)
| Biomarker | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | CAGR |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| North America | 11,277.8 | 12,643.2 | 14,198.3 | 15,784.8 | 17,572.1 | 19,588.1 | 21,864.8 | 24,656.4 | 27,923.3 | 31,803.8 | 36,429.4 | 41,963.5 | 48,609.9 | 14.5% |
| Europe | 6,817.6 | 7,559.6 | 8,396.3 | 9,231.6 | 10,163.0 | 11,202.9 | 12,364.9 | 13,786.8 | 15,436.9 | 17,382.3 | 19,682.9 | 22,412.6 | 25,662.7 | 13.2% |
| Asia Pacific | 3,287.7 | 3,729.9 | 4,239.2 | 4,770.0 | 5,374.9 | 6,064.9 | 6,853.2 | 7,823.9 | 8,970.7 | 10,345.1 | 11,998.7 | 13,996.1 | 16,418.7 | 16.0% |
| Latin America | 306.9 | 336.8 | 370.4 | 403.1 | 439.2 | 479.2 | 523.5 | 577.6 | 640.0 | 713.1 | 799.0 | 900.3 | 1,019.9 | 12.0% |
| MEA | 227.9 | 247.9 | 270.0 | 291.1 | 314.3 | 339.6 | 367.5 | 401.7 | 440.8 | 486.5 | 539.8 | 602.3 | 675.6 | 11.0% |
| Overall | 21,917.8 | 24,517.4 | 27,474.2 | 30,480.6 | 33,863.5 | 37,674.8 | 41,973.9 | 47,246.4 | 53,411.7 | 60,730.8 | 69,449.9 | 79,874.8 | 92,386.7 | 14.4% |
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
